Brief: Expres2ion Biotech Q2 Loss After Financial Items Widens To SEK 5.0 MILLION
Aug 20 (Reuters) - ExpreS2ion Biotech Holding AB EXPRS2.ST :
* Q2 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK 5.0 MILLION VERSUS LOSS SEK 3.6 MILLION YEAR
AGO
* Q2 GROUP TURNOVER SEK 4.0 MILLION VERSUS SEK 4.3 MILLION YEAR AGO
Source text for Eikon: ID:nWkr7cwvZD
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations